BTIG Maintains Buy on Jade Biosciences, Raises Price Target to $74

Benzinga Newsdesk www.benzinga.com Positive 78.1%

Neg 0% Neu 0% Pos 78.1%

BTIG analyst Julian Harrison maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $39 to $74.